Alice S. Kerber on Discussing Cancer Genetics With Patients

Article

Alice S. Kerber, MN, APRN, ACNS-BC, AOCN, APNG, Oncology Nurse Specialist, Georgia Center for Oncology Research and Education, provides advice on discussing cancer genetics with patients.

Alice S. Kerber, MN, APRN, ACNS-BC, AOCN, APNG, Oncology Nurse Specialist, Georgia Center for Oncology Research and Education, provides advice on discussing cancer genetics with patients.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with dark curly hair wearing a floral shirt
3 experts in this video
3 experts in this video
Image of a woman with gray hair on a light blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a private infusion bay with a large screen for video calls
2 experts are featured in this series.
Related Content
Opinion: Liquid Biopsy and Tissue Testing Yield Comparable Results for ROS1 in NSCLC

Opinion: Liquid Biopsy and Tissue Testing Yield Comparable Results for ROS1 in NSCLC

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
August 19th 2024
Article

Oncology nurses play a crucial role in educating patients about the significance of liquid biopsy in diagnosis and its use in evaluating resistance.

Breast Cancer Survivors May Not Undergo Genetic Testing, Counseling Regardless of Eligibility

Breast Cancer Survivors May Not Undergo Genetic Testing, Counseling Regardless of Eligibility

Roman Fabbricatore
August 16th 2024
Article

Genetic testing offers potential benefits after a cancer diagnosis by potentially reducing the risk for cancer in families with hereditary cancer syndromes and managing treatment.

dna genetics genomic tests © marina zlochin -adobe.stock.com.png

Out-of-Pocket Costs, Insurance Status May Impact Genomic Testing Rates

Kyle Doherty
April 10th 2024
Article

Genetic testing decisions in patients with cancer may be affected by significant out-of-pocket costs.

lung cancer

Should You Wait for NGS Results Before Initiating NSCLC Treatment?

Lindsay Fischer
November 17th 2023
Article

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

Are At-Home Genomic Tests Such as 23andMe Ethical?

Are At-Home Genomic Tests Such as 23andMe Ethical?

Lindsay Fischer
September 22nd 2023
Article

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, explains the pitfalls with at-home genomic tests and why nurses must be ready to talk to their patients about genetic counseling.

nurse with patient

Increase in Direct-to-Consumer Genomic Testing Yields New Ethical Considerations for Oncology Nurses

Lindsay Fischer
August 10th 2023
Article

Oncology nurses make the case for nurse intervention with direct-to-consumer genomic testing.